These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9331009)

  • 61. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
    Mann J
    Internist (Berl); 2007 Apr; 48(4):436-8. PubMed ID: 17342351
    [No Abstract]   [Full Text] [Related]  

  • 62. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
    Rosenborg S
    Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
    [No Abstract]   [Full Text] [Related]  

  • 63. TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model.
    Richter M; Westphal M; Maybaum B; Richter H; Skupin M; Mohr FW; Olbrich HG
    Transplant Proc; 1999; 31(1-2):106-7. PubMed ID: 10083031
    [No Abstract]   [Full Text] [Related]  

  • 64. Bioavailability of candesartan is unaffected by food in healthy volunteers administered candesartan cilexetil.
    Riddell JG
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S29-30. PubMed ID: 9331002
    [No Abstract]   [Full Text] [Related]  

  • 65. [New effects of telmisartan, an angiotensin 2 receptor blocker, in the treatment of arterial hypertension with metabolic disorders].
    Demin AA; Shuliat'eva OIu
    Klin Med (Mosk); 2012; 90(1):32-4. PubMed ID: 22567936
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacotherapy for prehypertension--mission accomplished?
    Schunkert H
    N Engl J Med; 2006 Apr; 354(16):1742-4. PubMed ID: 16537661
    [No Abstract]   [Full Text] [Related]  

  • 67. Hypertension control among African Americans: an urgent call for action.
    Lackland DT
    J Clin Hypertens (Greenwich); 2004 Jun; 6(6):333-4. PubMed ID: 15187495
    [No Abstract]   [Full Text] [Related]  

  • 68. CHARM shows improvement in NYHA functional class with candesartan.
    Cardiovasc J S Afr; 2004; 15(2):96-7. PubMed ID: 15148548
    [No Abstract]   [Full Text] [Related]  

  • 69. [A megatrial of ARB in Japan--CASE-J].
    Ogihara T
    Nihon Rinsho; 2002 Oct; 60(10):2045-9. PubMed ID: 12397705
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Switching from ACE inhibitors, beta-blockers, calcium antagonists or diuretics to candesartan improves efficacy and tolerability.
    Porcellati C; Omboni S
    Blood Press; 2002; 11(5):310-9. PubMed ID: 12458654
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Do we need angiotensin II antagonists to treat hypertensive patients?
    Ménard J; Chatellier G; Azizi M
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S1-7. PubMed ID: 9330998
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of an acute dose of 16 mg candesartan cilexetil on systemic and renal haemodynamics in hypertensive patients.
    Fridman K; Andersson OK; Wysocki M; Friberg P
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S43-4. PubMed ID: 9331005
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil.
    Mancia G; Grassi G
    J Hum Hypertens; 2000 Oct; 14 Suppl 2():S3-10. PubMed ID: 11086630
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Update on the clinical pharmacology of candesartan cilexetil.
    Gavras H
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):25S-30S. PubMed ID: 10678285
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiotensin II Receptor Antagonists: Can they Go Beyond ACE Inhibitors? Proceedings of a satellite symposium to the 15th scientific meeting of the International Society of Hypertension. Melbourne, Australia, March 1994.
    Blood Press Suppl; 1994; 5():1-133. PubMed ID: 7889189
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug companies should not have the final say in the design of clinical trials.
    Kurtzman NA
    Am J Kidney Dis; 2001 Nov; 38(5):1113-4. PubMed ID: 11684568
    [No Abstract]   [Full Text] [Related]  

  • 77. [Candesartan, angiotensin II receptor antagonist].
    Sasaguri M; Arakawa K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():144-8. PubMed ID: 11028310
    [No Abstract]   [Full Text] [Related]  

  • 78. [Angiotensin II receptor antagonists in arterial hypertension: new clinical evidence with candesartan].
    Mancia G; Turri C; Magnoni M; Grassi G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):439-42. PubMed ID: 12497948
    [No Abstract]   [Full Text] [Related]  

  • 79. Erythema multiforme associated with candesartan cilexetil.
    Ejaz AA; Walsh JS; Wasiluk A
    South Med J; 2004 Jun; 97(6):614-5. PubMed ID: 15255435
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Candesartan cilexetil in children and adolescents aged 1 to <17 years with hypertension: profile report.
    Hoy SM; Keating GM
    Paediatr Drugs; 2012 Feb; 14(1):61-2. PubMed ID: 22149551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.